UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action

Calcified tissue international, 2017-03, Vol.100 (3), p.229-234

2017

Volltextzugriff (PDF)

Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature

Journal of bone and joint surgery. American volume, 2004-05, Vol.86 (5), p.963-974

2004

Volltextzugriff (PDF)

PRM172 The Value of Personalized Medicine: It is More About Unveiling the Performance of the Companion Diagnostic

Value in health, 2012-11, Vol.15 (7), p.A492-A492

Ethgen, O

2012

Volltextzugriff (PDF)

PRM32 One Day Money Will Only Be Spent on Effective Drugs…from Payers' Aspirations to Performance-Based Risk-Sharing Operations

Value in health, 2012-06, Vol.15 (4), p.A164-A164

Ethgen, O

2012

Volltextzugriff (PDF)

Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures

Osteoporosis international, 2016-01, Vol.27 (1), p.301-308

2016

Volltextzugriff (PDF)

A budget optimization analysis for the treatment and potential elimination of hepatitis C virus infection in the United States

Journal of hepatology, 2017, Vol.66 (1), p.S748-S748

2017

Volltextzugriff (PDF)

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

Annals of the Rheumatic Diseases, 2004-07, Vol.63 (7), p.759-766

2004

Volltextzugriff (PDF)

Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective study

Archives of orthopaedic and trauma surgery, 2012-11, Vol.132 (11), p.1583-1587

2012

Volltextzugriff (PDF)

EE181 Cost-Effectiveness of Single-Pill Combination Versus Free-Equivalent Combination in the Management of Hypertension

Value in health, 2022-12, Vol.25 (12), p.S88-S88

2022

Volltextzugriff (PDF)

EE595 Did We Follow the Right Approach in Economic Evaluations by Discounting Health Gain?

Value in health, 2022-12, Vol.25 (12), p.S172-S172

2022

Volltextzugriff (PDF)

POSB127 Cost-Comparison of HBA1C reduction with Gliclazide-Modified Release or Sitaglipltin in Patients with Uncontrolled Type 2 Diabetes after Metformin Monotherapy

Value in health, 2022-01, Vol.25 (1), p.S86-S86

2022

Volltextzugriff (PDF)

Social Support and Health-Related Quality of Life in Hip and Knee Osteoarthritis

Quality of life research, 2004-03, Vol.13 (2), p.321-330

2004

Volltextzugriff (PDF)

Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis

Calcified tissue international, 2005-03, Vol.76 (3), p.176-186

2005

Volltextzugriff (PDF)

P1245 : Public health impact of HCV screening and treatment in the French baby-boomer population

Journal of hepatology, 2015-04, Vol.62, p.S824-S824

2015

Volltextzugriff (PDF)

Potential Risk-Sharing Agreements for Vaccines

Value in health, 2014-11, Vol.17 (7), p.A669-A670

2014

Volltextzugriff (PDF)

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

Osteoporosis international, 2004-04, Vol.15 (4), p.301-310

2004

Volltextzugriff (PDF)

PDB35 COST-EFFECTIVENESS OF GLICLAZIDE MR-BASED INTENSIVE GLUCOSE CONTROL VERSUS STANDARD GLUCOSE CONTROL IN TYPE 2 DIABETES MELLITUS. AN ECONOMIC ANALYSIS IN VIETNAM OF THE ADVANCE TRIAL

Value in health, 2019-11, Vol.22, p.S578-S578

2019

Volltextzugriff (PDF)

An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

Value in health, 2013-11, Vol.16 (7), p.A616-A616

2013

Volltextzugriff (PDF)

PRM170 Optimizing Public Health Decision Over Time: A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

Value in health, 2012-11, Vol.15 (7), p.A491-A491

2012

Volltextzugriff (PDF)

Economics of Dialysis Dependence Following Acute Kidney Injury (AKI) in the Intensive Care Unit (ICU)

Value in health, 2013-11, Vol.16 (7), p.A631-A631

2013

Volltextzugriff (PDF)

VA4 Found the Missing Link? How to Relate Cohort Models to Observed Population Data

Value in health, 2012-11, Vol.15 (7), p.A288-A288

2012

Volltextzugriff (PDF)

Contrats de risk-sharing : choix des schémas d’étude et des critères de jugement

Annales pharmaceutiques françaises, 2013-09, Vol.71 (5), p.346-357

2013

Volltextzugriff (PDF)

CO4 Cost-Effectiveness Analysis - Appropriate for All Situations?

Value in health, 2012-06, Vol.15 (4), p.A2-A2

2012

Volltextzugriff (PDF)

PHP100 Defining Elements of Value for Rare Disease Treatments

Value in health, 2012-06, Vol.15 (4), p.A31-A31

2012

Volltextzugriff (PDF)

PHP102 From Value to Price: What Should Be the Path for Orphan Drugs?

Value in health, 2012-06, Vol.15 (4), p.A31-A31

2012

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Englisch
(102)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Humans
(36)
Human Health Sciences
(33)
Sciences De La Santé Humaine
(33)
Female
(28)
Aged
(26)
Middle Aged
(23)
Male
(20)
Biological And Medical Sciences
(19)
Internal Medicine
(19)
Medical Sciences
(18)
Health Care Sciences & Services
(16)
Health Policy & Services
(16)
Diseases Of The Osteoarticular System
(13)
Rheumatology
(13)
Aged, 80 And Over
(12)
General & Internal Medicine
(11)
Osteoarthritis
(11)
Osteoporosis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action

Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature

PRM172 The Value of Personalized Medicine: It is More About Unveiling the Performance of the Companion Diagnostic

PRM32 One Day Money Will Only Be Spent on Effective Drugs…from Payers' Aspirations to Performance-Based Risk-Sharing Operations

Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures

A budget optimization analysis for the treatment and potential elimination of hepatitis C virus infection in the United States

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective study

EE181 Cost-Effectiveness of Single-Pill Combination Versus Free-Equivalent Combination in the Management of Hypertension

EE595 Did We Follow the Right Approach in Economic Evaluations by Discounting Health Gain?

POSB127 Cost-Comparison of HBA1C reduction with Gliclazide-Modified Release or Sitaglipltin in Patients with Uncontrolled Type 2 Diabetes after Metformin Monotherapy

Social Support and Health-Related Quality of Life in Hip and Knee Osteoarthritis

Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis

P1245 : Public health impact of HCV screening and treatment in the French baby-boomer population

Potential Risk-Sharing Agreements for Vaccines

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

PDB35 COST-EFFECTIVENESS OF GLICLAZIDE MR-BASED INTENSIVE GLUCOSE CONTROL VERSUS STANDARD GLUCOSE CONTROL IN TYPE 2 DIABETES MELLITUS. AN ECONOMIC ANALYSIS IN VIETNAM OF THE ADVANCE TRIAL

An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

PRM170 Optimizing Public Health Decision Over Time: A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

Economics of Dialysis Dependence Following Acute Kidney Injury (AKI) in the Intensive Care Unit (ICU)

VA4 Found the Missing Link? How to Relate Cohort Models to Observed Population Data

Contrats de risk-sharing : choix des schémas d’étude et des critères de jugement

CO4 Cost-Effectiveness Analysis - Appropriate for All Situations?

PHP100 Defining Elements of Value for Rare Disease Treatments

PHP102 From Value to Price: What Should Be the Path for Orphan Drugs?

Suchergebnisse filtern